A Day Up For Ocular Therapeutix, Inc.
Thu, Sep 29, 2022 at 07:33 PM
Ocular Therapeutix, Inc. (OCUL:NASDAQ) soared at $5.13, representing a gain of 24.2%. On Thu, Sep 29, 2022, OCUL:NASDAQ hit a New 2-Week Intraday Low of $3.97. The stock appeared on our News Catalysts scanner on Tue, Sep 27, 2022 at 02:35 PM in the 'BIOTECH' category. From Thu, Sep 15, 2022, the stock recorded 30.00% Up Days and 45.45% Green Days
About Ocular Therapeutix, Inc. (OCUL:NASDAQ)
Ocular Therapeutix Inc is a biopharmaceutical company. It is engaged in developing and commercializing therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology.
Top 10 Gainers:
- Senti Biosciences Inc Com (SNTI:NASDAQ), 50.71%
- BigBear.ai Inc. (BBAI:NYSE), 30.25%
- Vertical Aerospace Ltd. (EVTL:NYSE), 27.18%
- TuanChe Limited (TC:NASDAQ), 25.31%
- Ocular Therapeutix, Inc. (OCUL:NASDAQ), 24.21%
- BioTelemetry, Inc. (BEAT:NASDAQ), 21.51%
- Sientra, Inc. (SIEN:NASDAQ), 20.98%
- AEA-Bridges Impact Corp. Class A (IMPX:NYSE), 20.69%
- Jupiter Wellness Inc. (JUPW:NASDAQ), 20.53%
- Akouos Inc. (AKUS:NASDAQ), 16.88%